A phase IIa study to evaluate the safety, pharmacodynamics and pharmacokinetics of TGN255 in stable haemodialysis patients

被引：0
|
作者：
Combe, Sophie
DSouza, Richard
Mysliwiec, Michal
Padmanabhan, Neal
Thomas, Mark
Villa, Giuseppe
Will, Eric
Patrick, Guy
Kennedy, Anthony
机构：
[1] Trigen, London, England
[2] Royal Devon & Exeter Hosp, Exeter Kidney Unit, Exeter EX2 5DW, Devon, England
[3] Bialystok Med Univ, Bialystok, Poland
[4] Univ Glasgow, Western Infirm, Glasgow G11 6NT, Lanark, Scotland
[5] Birmingham Heartlands Hosp, Glaxo Renal Unit, Birmingham B9 5ST, W Midlands, England
[6] Fdn S Maugeri, Pavia, Italy
[7] St James Univ Hosp, Leeds LS9 7TF, W Yorkshire, England
[8] Premier Res, Crowthorne, Berks, England
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2006年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
引用
收藏
页码：215 / 216
页数：2
相关论文
共 50 条
  • [41] Phase I Study to Determine the Pharmacokinetics, Pharmacodynamics, and Safety of IV Ganaxolone in Healthy Adults
    Tsai, Julia
    Guptill, Jeffrey T.
    MacLeod, David B.
    Husain, Aatif
    Patroneva, Albena
    ANNALS OF NEUROLOGY, 2016, 80 : S77 - S78
  • [42] Phase 1 study to access safety, tolerability, pharmacokinetics, and pharmacodynamics of kynurenine in healthy volunteers
    Al-Karagholi, Mohammad Al-Mandi
    Hansen, Jakob Moller
    Abou-Kassem, Dalia
    Hansted, Anna Koldbro
    Ubhayasekera, Kumari
    Bergquist, Jonas
    Vecsei, Laszlo
    Jansen-Olesen, Inger
    Ashina, Messoud
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2021, 9 (02):
  • [43] A phase 1 study of the safety, tolerability, pharmacodynamics, and pharmacokinetics of tenapanor in healthy Japanese volunteers
    Johansson, Susanne
    Rosenbaum, David P.
    Knutsson, Mikael
    Leonsson-Zachrisson, Maria
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2017, 21 (03) : 407 - 416
  • [44] PHARMACOKINETICS (PK), PHARMACODYNAMICS (PD), AND SAFETY OF TICAGRELOR IN CHINESE PATIENTS WITH STABLE CORONARY HEART DISEASE (CHD)
    Li, H.
    Guo, J.
    Carlson, G. F.
    Teng, R.
    CARDIOLOGY, 2015, 132 : 285 - 285
  • [45] A Phase 1, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneously Administered SRSD107 in Healthy Subjects
    Yue, Patrick
    Qu, Emma
    Pan, Jie
    Weitz, Jeffrey
    Ji, Qunsheng
    BLOOD, 2024, 144 : 4009 - 4010
  • [46] A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Recombinant Human Hyaluronidase PH20 Administered Intravenously in Healthy Volunteers
    Printz, Marie A.
    Dychter, Samuel S.
    DeNoia, Emanuel P.
    Harrigan, Rena
    Sugarman, Barry J.
    Zepeda, Monica
    Souratha, Jennifer
    Kang, David W.
    Maneval, Daniel C.
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2020, 93
  • [47] Phase 1 dose-escalating study to evaluate the safety, pharmacokinetics, and pharmacodynamics of a recombinant factor Xa variant (FXaI16L)
    Parsons-Rich, D.
    Hua, F.
    Li, G.
    Kantaridis, C.
    Ittman, D. D. P.
    Arkin, S.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2017, 15 (05) : 931 - 937
  • [48] An Open-Label, Phase 1 Study to Evaluate the Effects of Hepatic Impairment on Edoxaban Pharmacokinetics and Pharmacodynamics
    Mendell, Jeanne
    Johnson, Lisa
    Chen, Shuquan
    JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 55 (12): : 1395 - 1405
  • [49] Safety, tolerability, pharmacokinetics, and efficacy of kukoamine B in patients with sepsis: A randomized phase IIa trial
    Hu, Xiao-Yun
    Zhang, Weiwen
    Wang, Difen
    Sun, Yunbo
    Hu, Zhenjie
    Zang, Bin
    Feng, Yongwen
    Wang, Huaxue
    Zhou, Jianxin
    Zhao, Qian
    Liu, Hongzhong
    Wang, Teng
    Jiang, Wei
    Wang, Chun-Yao
    Jin, Chunyan
    Dong, Kai
    Chen, Shuai
    Yao, Xiaoqing
    Hu, Pei
    Du, Bin
    JOURNAL OF CRITICAL CARE, 2023, 76
  • [50] Pharmacokinetics, Pharmacodynamics and Safety of Belimumab in Chinese Patients with Systemic Lupus Erythematosus: A Phase I, Open-Label Study
    Zhang, Jing
    Wan, Weiguo
    Miao, Liyan
    Wu, Jian
    Dong, Jun
    Shen, Yinghua
    Xiong, Cui
    Li, Chao
    Xue, Yu
    Cao, Guoying
    Ma, Peiming
    RHEUMATOLOGY AND THERAPY, 2020, 7 (01) : 191 - 200
12345